 neurosyphili human immunodefici viru type individu prospect studi preval neurosyphili human immunodefici viru type -seroposit hiv+ person cours studi neurolog complic infect sixty-six asymptomat hiv+ subject symptomat hiv+ subject at-risk hiv- control underw cerebrospin fluid csf analysi entri longitudin studi three asymptomat hiv+ subject reactiv csf vdrl test reactiv csf fluoresc treponem antibody-absorpt fta-ab test subject histori earli syphili reactiv serum rapid plasma reagin test symptomat hiv+ subject patient dementia reactiv csf vdrl test fluoresc treponem antibody-absorpt test subject improv cognit skill high-dos intraven penicillin therapi subject penicillin-respons myelopathi reactiv csf fluoresc treponem antibody-absorpt test result nonreact csf vdrl neurosyphili common popul asymptomat hiv+ subject respons neurolog diseas signific minor symptomat hiv+ person cerebrospin fluid examin hiv+ person histori syphili serolog evid syphili prior treatment neurosyphili differenti diagnosi neurolog diseas hiv+ person